The immune system has the unique capacity to interact with almost every tissue in the body to promote protection against threats and to preserve organismal homeostasis. Understanding how immune cells adapt their function to the needs of each distinct tissue environment is challenging. It requires thinking about immunity in the context of a whole organism, where immune function is integrated to other physiological systems – such as the nervous system, metabolic tissues and barrier sites – as well as to our meta-organismal partner: the microbiome.
To help to address this challenge, the Cell-Weizmann Institute of Science Symposium: Next Gen Immunology is bringing together leading scientists who think about immunity in different contexts and have in common the perspective of an immune system that is an integral part of the meta-organism. They are also driving the development of new tools that are much needed to understand the functional diversity of the immune response: from live in vivo imaging and single-cell technologies, to ‘omics’ approaches.
We aim to stimulate exciting discussions, to foster new interdisciplinary collaborations, and to promote cross-pollination of ideas that can help us to move on to the next generation of immunology research. We hope to see you there!
The Texas Department of State Health Services, Cameron County Department of Health & Human Services, and City of South Padre Island would like to invite you on February 14-16, 2018 to the Hilton Garden Inn at South Padre Island, Texas for the 3rd Annual South Texas Tropical Medicine & Vector Borne Disease Conference.
The main emphasis for this event is to promote awareness of vector borne diseases and the interdisciplinary approach involved in controlling and preventing vector borne diseases.
Continuing education credit for multiple disciplines will be provided for this event.
The South Texas Tropical Medicine & Vector Borne Disease Conference is the 1st ever interdisciplinary vector borne disease specific conference relevant to the South Texas region. General sessions will include presentations on topics such as vector biology, vector control emergency management, vector borne disease pathology, epidemiology, public health, vector control techniques, laws, and regulations. Such broad & varying topics demand transdisciplinary approaches for effective prevention and control methods.
This meeting, the second of a continual series of biennial ISIRV meetings on this topic, aims to be the premier global meeting on respiratory viruses, bacteria, and other pathogens.
Respiratory pathogens result in substantial burden of disease and costs to communities globally. They range from emerging and re-emerging diseases such as avian influenza viruses, MERS-CoV, pertussis, tuberculosis, and antimicrobial resistant pathogens; to endemic diseases that result in high morbidity and severe cases with mortality.
Despite the impact of these diseases, substantial gaps remain in our understanding of their burden and epidemiology, the interactions between different pathogens, their immunology and pathogenicity, and how to diagnose and manage these diseases. There is also a lack of vaccine and therapeutic options that are urgently needed. Many of these research gaps have been identified by the World Health Organization’s Battle against Respiratory Viruses (BRaVe) initiative.
This meeting will focus on addressing these gaps through the sharing of recent advances in epidemiology, immunology, diagnostics, vaccines and therapeutics and clinical management. It will bring together clinicians, public health professionals, scientists, and policy makers to learn about respiratory pathogens, and discuss what are the next steps in reducing the burden of these diseases through research and policy initiatives. This includes specific sessions devoted to providing updates for policy makers to increase their understanding on respiratory diseases and to allow for better research-policy interactions that will accelerate translational research.
We are aiming to attract 400 international participants to this 3-day conference, and hope that through our collective efforts we can effectively combat respiratory pathogens.
The meeting is being held in Singapore, one of the smallest, yet most beautiful, countries in the world - almost "Heaven on Earth". Well-connected to all corners of the globe and affordable to all, this island nation is also the gateway to the wonders, pleasures and experiences of South-East Asia and the Far East.
We look forward to welcoming you to Singapore and making your participation in IMRP 2018 a success for your organisation and an opportunity to create partnerships with many like-minded groups for years to come.
The Cancer Drug Development Forum (CDDF) in collaboration with the Society for Immunotherapy of Cancer (SITC) has the great pleasure to invite you to take part in the 5th Immunotherapy of Cancer Conference (ITOC5) – the leading International conference in Europe providing a global platform for translational research in the field of immuno-oncology.
The ITOC series of conferences is the premier meeting for education, scientific exchange, and networking within the cancer immunotherapy field.
It aims at providing a forum for all professionals working in immunotherapy to discuss early clinical drug development and address the unique challenges of translational research.
The programme will focus on the latest challenges and innovations with a special emphasis on combination therapy, immuno-monitoring and biomarker development.
At this conference, we are in particular addressing preclinical and clinical scientists, clinical investigators, postdoctoral fellows involved in cancer research, regulatory scientists, healthcare professionals and the pharmaceutical industry
Join us in Berlin, Germany on 19 – 21 March 2018 to help push further the opportunities that will ultimately aid in revolutionising the way cancer is treated.
The International Symposiumon Pneumococci and Pneumococcal Diseases (ISPPD) is the premier global scientific symposium devoted to the exchange, advancement and dissemination of the latest discoveries on the basic science, microbiology, epidemiology, treatment and prevention of pneumococci and pneumococcal disease.
ISPPD provides an unparalleled international forum to bring together scientific, clinical and public health experts, practitioners, and students to present, discuss, challenge and learn from the latest work and advancements on pneumococcal disease.
Discover the latest achievements in the fight against the pneumococcus at ISPPD-11, 5-19 April, 2018, Melbourne, Australia.
This meeting will retain the format, and build on the success of the previous NIV symposiums held in Atlanta 2015, Dublin 2013 and Florida in 2010. It will explore the latest data on surveillance and disease investigation, virus transmission and control, clinical and experimental virology, and emerging issues and new developments related to swine, equine, canine and other non-human/non-avian influenza viruses.
Goals and Objectives
To promote a transdisciplinary, coordinated 'One Health' approach to the control of influenza by integrating the scientific input from public health, veterinary health, environmental health, and basic science.
The 27th Annual Canadian Conference on HIV/AIDS Research is the premier gathering in Canada for those working in all disciplines of HIV/AIDS research, as well as policy makers, persons living with HIV and other individuals committed to ending the pandemic.
This year’s conference theme is Celebrating our Diversity: Uniting in the Response to HIV
In this the 27th year of the CAHR conference we look back at the achievements of the last three decades and forward to the work we have yet to do. Since its emergence in the early 1980’s, HIV has changed us. HIV takes no prisoners, and kills indiscriminately of age, race or gender.
Together we have fought back in many ways, both on the prevention and the treatment front. There are now close to 20 million people accessing antiretroviral treatment. Pre-exposure prophylaxis and maternal antiretroviral therapy are preventing new infection, and we are getting closer in our search for an effective vaccine, and a cure. Over the past decades, the face of HIV/AIDS research has also changed and CAHR, as an organization, should reflect those changes.
This year at CAHR 2018, we endeavour to acknowledge and celebrate diversity among both people with lived experience of HIV, as well as among HIV researchers. More than ever members of the community and key affected populations are generating ground-breaking research. In this quest against HIV, we have learned that we can accomplish more together when we embrace our diversity as people with unique lived experiences, perspectives and ideas to contribute. Uniting groups of researchers from multiple tracks – health care professionals, community workers, academics, trainees, educators, activists, volunteers, people with lived experience of HIV, and policy makers – we have many objectives to pursue in order to improve the lives of people living with HIV, and prevent new infections.
We invite you to join us next April for CAHR 2018, in beautiful Vancouver on the unceded territory of the Musqueam, Squamish and Tsleil-Waututh First Nations. In this place, let’s celebrate our diversity as peoples affected by HIV, and as HIV researchers; let’s unite in our response to HIV.
Please keep visiting the conference site for updates.
AMMI Canada and CACMID are pleased to invite you to THE Canadian annual meeting in infectious diseases and microbiology. The 2018 AMMI Canada – CACMID Annual Conference will take place in Vancouver, BC, from May 2-5, and promises another great program!
The 2018 meeting will address topics including:
DISCOVER the latest in original research from young and established investigators
ENGAGE with world-renowned experts in the basic and clinical sciences
BELONG to a network of cross-disciplinary colleagues who support academic pediatrics
The Pediatric Academic Societies (PAS) Meeting brings together thousands of pediatricians and other health care providers united by a common mission: improve the health and well-being of children worldwide. This international gathering includes researchers, academics, as well as clinical care providers and community practitioners. Presentations cover issues of interest to generalists as well as topics critical to a wide array of specialty and sub-specialty areas.
We are excited to share with you the first-ever strategic plan for the Pediatric Academic Societies (PAS) Meeting!
This plan, recently adopted by the PAS Meeting Executive Committee, builds upon the historic success of the PAS Meeting and codifies our aspirational vision:
The PAS Meeting will be the premier North American scholarly child health meeting.
EAACI Congress 2018
Organised by the European Academy of Allergy and Clinical Immunology (EAACI), Europe’s largest medical association in the field of allergy and clinical immunology, the EAACI Congress 2018 offers a unique opportunity to learn about the latest discoveries. With healthcare professionals and key opinion leaders joining from around the world, this meeting offers an excellent platform for knowledge exchange, learning and networking.
This year’s EAACI Congress will take place in Munich, Germany from 26 - 30 May 2018 at the ICM - Internationales Congress Center München.
We look forward to seeing you there!
WELCOME TO ESPID 2018
Join us for the 36th Annual Meeting of the European Society for Paediatric Infectious Diseases. Thousands of clinicians, researchers, residents, and students will come together on May 28–June 2 in Malmö, Sweden. Building on the success and innovation of previous meetings, ESPID 2018 will feature a wide range of sessions and learning opportunities showcasing the latest research and developments in the field hosted by leading international experts. Experience excellence in Malmö at ESPID 2018!
The Society for Natural Immunity (SNI) is excited to plan the 17th Meeting, NK2018, which will be held in San Antonio, Texas, May 28 – June 1, 2018. On behalf of the NK2018 Planning Committee, Drs. Jordan Orange, Katy Rezvani, Krishna Vankayalapati, Silke Paust, Emily Mace, and Audrea Burns, we hope that the involvement and support of the University of Western Australia will be a part of the 17th Meeting.
The Western University is located in London, ON (the “Forest City”) and is one of Canada’s oldest and most beautiful campus, surrounded by beautiful gardens and trees with a mix of gothic and modern architecture. Western is located approximately 20 minutes from the London International Airport with direct flights to/from Toronto, Ottawa, Montreal, Winnipeg, Calgary.
The meeting will consist of:
The Local Organizing Committee from Western University will consist of:
Mansour Haeryfar (Chair)
Thirty years of Dendritic Cell Symposia created a unique and world-wide operating network of research groups dedicating their work to better understand the role of dendritic cells in health and disease and to harness their therapeutic potential. Initiated by the discovery of Ralph Steinman at Rockefeller University, New York, in the early 1970s, European scientists were attracted by this exciting field of research early on and continue to make major contributions.
Thus, it is our great pleasure to invite you to join us at the 15th International Symposium on Dendritic Cells in historic Aachen. This city is not only located in today’s tri-state-area between, Belgium, The Netherlands and Germany but also represents a true European place having been home to Celtics, Romans, Merovingians and Franconians alike in the past.
Malaria remains a preventable global health emergency and a disease whose results continue to immure individuals, communities and countries in poverty. However with a multisector approach working across scientific innovation, health systems delivery, governments, non-governmental organizations and affected communities, malaria can be eradicated.
The global malaria situation has improved dramatically over the last fifteen years. The number of deaths and illnesses due to malaria has effectively halved although this varies between and within countries. These successes have been achieved through the extraordinary cooperation of affected communities and their governments, working alongside governments of donor nations, multilateral bodies, researchers, philanthropic organisations, private sector organisations and non-government agencies. However, without coordinated action, these impressive gains will be difficult to sustain and even more difficult to accelerate. This ambitious program could so easily be derailed by a misplaced confidence that the job is nearly done and a lack of understanding of the challenges that still face us. We must act now to ensure the momentum and achievements of the past 15 years continue to build. We do not want history to repeat itself and malaria to come bounding back. Elimination and eradication of malaria is possible, but requires new tools as well as innovative approaches that engage communities living with the disease.
A major gap in the malaria response landscape is the absence of a forum where representatives of the entire malaria world can meet. Our key aim for the inaugural World Congress on Malaria is to unify and energise the broader malaria community around a common sense of purpose, including one that links malaria with the wider global health and human development goals of Universal Health Coverage and the Sustainable Development Goals. Together we can learn from each other, plan for the implementation of cross sector strategies and galvanise the effort for the eradication of malaria.
The conference sessions will feed into a final round table discussion leading to joint declarations by Global and Asia Pacific leaders committing to the goal of Malaria Elimination in our region by 2030 and a roadmap for steps and targets needed to achieve this.
Join us at this significant event to make malaria history.
Professor Alan Cowman FAA FRS Walter and Eliza Hall Institute of Medical Research
Professor Brendan Crabb AC Burnet Institute
Assoc. Professor Helen Evans (Hon) AO Nossal Institute for Global Health and Burnet Institute
Thanks to the success of the inaugural Mucosal Immunology Course & Symposium (MICS) held in Toronto, Canada in 2016, SMI is pleased to announce the 2nd annual MICS event will take place at the Examination Schools at Oxford University in the United Kingdom!
We have developed a broad scientific program incorporating the latest ideas and concepts of immunity at mucosal surfaces. The meeting aims to provide a forum to stimulate synergistic interactions between both basic and clinical scientists to further our understanding of key topics in mucosal immunology. These include host-pathogen interactions at mucosal surfaces, developmental aspects of mucosal immunity, regulation of mucosal inflammation and tissue repair and gene-environment interactions in mucosal diseases. By considering findings from model systems, physiology and human disease across a range of mucosal sites, we also aim to obtain insights into conserved and tissue-specific circuits in mucosal homeostasis.
Please stay tuned to this page and upcoming SMI communications for important updates and more information in the upcoming months!
CDC will host the next International Conference on Emerging Infectious Diseases (ICEID) August 26–29, 2018, at the Omni Atlanta Hotel at CNN Center in Atlanta, GA. Held every 2–3 years, the conference brings together more than 1500 public health professionals from around the world to encourage the exchange of the latest information on issues affecting the emergence, spread, and control of infectious disease.
Organized in collaboration with the Task Force for Global Health and with scientific input from more than 30 national and global partners, ICEID 2018 will mark the 10th occurrence of this premier infectious disease conference. The program includes plenary and panel sessions with invited speakers, oral abstract and poster presentations, and multiple scientific and public health exhibitors—all focusing on emerging and re-emerging infections.
Major topics for ICEID 2018 include surveillance and outbreak response, laboratory diagnostics and systems, factors contributing to disease emergence and control, and public health preparedness. Specific subjects focus on issues such as antimicrobial resistance, genomic and molecular epidemiology, foodborne and waterborne illnesses, vector-borne and zoonotic diseases, healthcare-associated infections, respiratory infections, and global health.
Welcome from ECI 2018 Congress President
It is with great pleasure that we welcome you on behalf of the Dutch Society of Immunology (NVVI) to the 5th European Congress of Immunology (ECI) in Amsterdam from September 2-5, 2018.
The 5th ECI will cover all fields of modern immunology, ranging from innate memory and tissue specific regulation of T and B cell differentiation to unsupervised analyses of big data for diagnostics and combinational immunomodulatory biologicals.
The special focus of the 5th ECI will be ‘Building Bridges’. The Dutch take pride in being expert bridge builders, physically to live among opulent environmental water, but also figuratively to connect people and facilitate mutual goals. We aim to show you that this pride is not delusional.
In the meeting we will specifically dedicate sessions to identify new discoveries in fundamental immunology that hold diagnostic and therapeutic promise and to tackle challenges that arise from connecting fundamental and translational science.
We will bring in scientists from interdisciplinary fields, like data management, systems biology and multidimensional systems imaging to form beachheads for novel directions of immunological research and optimised evaluations of clinical trials.
We will do our best to make the 5th ECI a most memorable scientific event for you. We very much look forward to hosting you in Amsterdam in September 2018!
Organized by Vaccine, the premier journal for those interested in vaccine science, the 12th Vaccine Congress will bring together leading experts from all over the world to share the latest cutting-edge discoveries in the field.
Join us in Budapest, Hungary in September 2018 to hear top-notch invited speakers present state-of-the-art lectures in the field of vaccinology, and to have the opportunity to share and present your own research, as well as form new relationships with potential collaborators!
It is our great pleasure to invite you to the 21st ESCV Annual Meeting which will be held in Athens, 23-26 September, 2018.
The ESCV Annual Meeting has been a major event for the Clinical Virology scientific community and it is becoming more popular, comprehensive, innovative and influential, while maintaining high standards of scientific quality and a family atmosphere. The 21st ESCV Annual Meeting is promising to be an exciting event, covering all timely topics of Clinical Virology, enabling delegates to exchange knowledge with world’s leading experts, network with colleagues and discuss the latest advances on “traditional” and emerging viruses.
We look forward to welcoming you in Athens in September 2018, eager to exchange views on our field and ready to enjoy the marvelous late summer overlooking the Aegean coastline.
It is with much pleasure and anticipation that we announce the ESMO 2018 Congress will take place 19-23 October 2018, in Munich, Germany. ESMO invites all oncology stakeholders: researchers, clinicians, industry partners, patient advocates and members of the press to mark your calendars for the annual ESMO Congress in 2018.
ESMO is and continues to be a leading force of high-quality oncology education, a platform for immense international visibility for scientific research, and a proud contributor to continuous improvements in patient care.
We invite you to save the date.
At IMMUNOLOGY 2018™, you’ll hear from global leaders in immunology and talented early-career investigators alike—all discussing breakthroughs across the full spectrum of topics in the field.
You’ll be meeting in Austin, the “Live Music Capital of the World,” deep in the heart of Texas. Enjoy blues, rock, and country music, amazing cuisine, and myriad attractions. With so much to do alongside a robust scientific program, make plans now to join us there!